Colchicine for Stroke Prevention (CHANCE-3 Trial) 
Study Type: Randomized, placebo-controlled trial
Setting: 244 hospitals in China
Participants: 8,343 patients (age ≥40) with minor/moderate ischemic stroke or TIA & hs-CRP ≥2 mg/L Intervention vs. Control 
Colchicine Group (n=4,176)• 0.5 … Read More
colchicine
CHANCE-3 Trial: Colchicine in Acute Stroke
AIRTRIP Trial Summary: Anakinra in Recurrent Pericarditis
2016 AIRTRIP TRIAL Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and dependance M Multicenter, double-blind, placebo-controlled, open-label, medication withdrawal study Objective: To determine the efficacy of anakinra for colchicine-resistant and corticosteroid-dependent recurrent pericarditis 21 Inclusion criteria: … Read More